Funders [new]

The IMPC has several major funders and industry sponsors. All partners in the IMPC have their own funding streams, either in the form of grants or national funding.

NIH

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives. Website.

As a large majority of IMPC funding comes from the NIH. The NIH Knockout Mouse Programme (KOMP2) project funds many of the centres.

Current NIH funding for the IMPC/KOMP2 includes: (UM1) RFA-RM-15-017, (U54) RFA-RM-10-012, (U54) RFA-RM-10-011, (U54) RFA-RM-10-012, (U42) RFA-RM-10-013.

For full funding details, please see the NIH’s KOMP Funded Research page and Funding Opportunities page.

Genome Canada

Genome Canada is a not-for-profit organization, funded by the Government of Canada. We act as a catalyst for developing and applying genomics+ and genomic-based technologies to create economic and social benefits for Canadians. Website.

Genome Canada funds NorCOMM2, an international phenotyping effort that contributes to IMPC data. Phenotyping for the NorCOMM2 project is based at our consortium member The Centre for Phenogenomics (TCP).

Both Genome Canada and Ontario Genomics fund NorCOMM2 via OGI-051.

CIHR Institute of Genetics / IRSC Institut de Génétique

The Canadian Institutes of Health Research (CIHR) is Canada’s federal funding agency for health research. Composed of 13 Institutes, we collaborate with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system. Website.

Medical Research Council, UK

The Medical Research Council (MRC) is part of the UK Research and Innovation (UKRI). The MRC invests in research on behalf of UK taxpayers, covering research in infections and immunity, molecular and cellular medicine, neurosciences and mental health, population and systems medicine, global health and translational research. Website.

The MRC awarded funding to MRC Harwell for the IMPC project under the project reference MC_UP_1502/3.

Infrafrontier

The Infrafrontier project is funded by the EU and funds the infrastructure used by some members of the IMPC. Infrafrontier also funds annual conferences, jointly organised by the IMPC that showcase the latest research involving animal models.

Infrafrontier grant 01KX1012; EU Horizon2020: IPAD-MD funding 653961; EUCOMM: LSHM-CT-2005-018931, EUCOMMTOOLS: FP7-HEALTH-F4-2010-261492.

Some other grants funding IMPC

The French National Centre for Scientific Research (CNRS), the French National Institute of Health and Medical Research (INSERM), the University of Strasbourg and the “Centre Europeen de Recherche en Biomedecine”, and the French state funds through the “Agence Nationale de la Recherche” under the frame programme Investissements d’Avenir labelled (ANR-10-IDEX-0002-02, ANR-10-LABX-0030-INRT, ANR-10-INBS-07 PHENOMIN).

The IMPC Newsletter

Get highlights of the most important data releases, news and events, delivered straight to your email inbox

Subscribe to newsletter